Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ILK |
| Upstream (Parents) |
|---|
| (<<) CFL1 → ILK |
| (<<) CHAF1A → ILK |
| (<<) EFEMP2 → ILK |
| (<<) IGFBP4 → ILK |
| (<<) ITGA5 → ILK |
| (<<) ITGB1 → ILK |
| (<<) MMP14 → ILK |
| (<<) MMP19 → ILK |
| (<<) MYL9 → ILK |
| (<<) PTMA → ILK |
| (<<) RHOC → ILK |
| (<<) RRAS → ILK |
| (<<) TGFB1 → ILK |
| (<<) THY1 → ILK |
| (<<) TIMP3 → ILK |
| (<<) TPP1 → ILK |
| (<<) YWHAH → ILK |
| Downstream (Children) |
|---|
| ILK → ACTC1 (>>) |
| ILK → BMP1 (>>) |
| ILK → CREB3L1 (>>) |
| ILK → DEAF1 (>>) |
| ILK → DYRK1A (>>) |
| ILK → GPX3 (>>) |
| ILK → HMOX1 (>>) |
| ILK → ISLR (>>) |
| ILK → MMP2 (>>) |
| ILK → MXRA8 (>>) |
| ILK → ORC6L (>>) |
| ILK → PLAU (>>) |
| ILK → RASA1 (>>) |
| ILK → RHOG (>>) |
| ILK → TPM4 (>>) |
| ILK → UBE2J1 (>>) |
